RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes
| dc.contributor.author | Rot, Antal | deu |
| dc.contributor.author | Krieger, Martin | deu |
| dc.contributor.author | Brunner, Thomas | |
| dc.contributor.author | Bischoff, Stephan | deu |
| dc.contributor.author | Schall, Thomas | deu |
| dc.contributor.author | Dahinden, Clemens | deu |
| dc.date.accessioned | 2011-10-25T06:31:23Z | deu |
| dc.date.available | 2011-10-25T06:31:23Z | deu |
| dc.date.issued | 1992 | |
| dc.description.abstract | The cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells. This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties. We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP-1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions. RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a. MIP-1 alpha also induced eosinophil migration, however, with lower efficacy. RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B-treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl-leucyl-phenylalanine (FMLP). RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a. RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors. No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors. Despite its weaker eosinophil-activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes. Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation. MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested. Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate. | eng |
| dc.description.version | published | |
| dc.identifier.citation | First publ. in: Journal of Experimental Medicine ; 176 (1992), 6. - pp. 1489-1495 | deu |
| dc.identifier.doi | 10.1084/jem.176.6.1489 | deu |
| dc.identifier.ppn | 352227249 | deu |
| dc.identifier.uri | http://kops.uni-konstanz.de/handle/123456789/14340 | |
| dc.language.iso | eng | deu |
| dc.legacy.dateIssued | 2011-10-25 | deu |
| dc.rights | terms-of-use | deu |
| dc.rights.uri | https://rightsstatements.org/page/InC/1.0/ | deu |
| dc.subject.ddc | 570 | deu |
| dc.title | RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes | eng |
| dc.type | JOURNAL_ARTICLE | deu |
| dspace.entity.type | Publication | |
| kops.citation.bibtex | @article{Rot1992RANTE-14340,
year={1992},
doi={10.1084/jem.176.6.1489},
title={RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes},
number={6},
volume={176},
issn={0022-1007},
journal={Journal of Experimental Medicine},
pages={1489--1495},
author={Rot, Antal and Krieger, Martin and Brunner, Thomas and Bischoff, Stephan and Schall, Thomas and Dahinden, Clemens}
} | |
| kops.citation.iso690 | ROT, Antal, Martin KRIEGER, Thomas BRUNNER, Stephan BISCHOFF, Thomas SCHALL, Clemens DAHINDEN, 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. In: Journal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489 | deu |
| kops.citation.iso690 | ROT, Antal, Martin KRIEGER, Thomas BRUNNER, Stephan BISCHOFF, Thomas SCHALL, Clemens DAHINDEN, 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. In: Journal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489 | eng |
| kops.citation.rdf | <rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14340">
<dc:contributor>Brunner, Thomas</dc:contributor>
<dc:contributor>Bischoff, Stephan</dc:contributor>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:creator>Dahinden, Clemens</dc:creator>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-25T06:31:23Z</dcterms:available>
<dc:contributor>Krieger, Martin</dc:contributor>
<dc:contributor>Dahinden, Clemens</dc:contributor>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dcterms:issued>1992</dcterms:issued>
<dcterms:abstract xml:lang="eng">The cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells. This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties. We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP-1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions. RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a. MIP-1 alpha also induced eosinophil migration, however, with lower efficacy. RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B-treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl-leucyl-phenylalanine (FMLP). RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a. RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors. No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors. Despite its weaker eosinophil-activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes. Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation. MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested. Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate.</dcterms:abstract>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-25T06:31:23Z</dc:date>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dc:creator>Krieger, Martin</dc:creator>
<dc:contributor>Schall, Thomas</dc:contributor>
<dc:rights>terms-of-use</dc:rights>
<dc:creator>Brunner, Thomas</dc:creator>
<dc:creator>Rot, Antal</dc:creator>
<dc:contributor>Rot, Antal</dc:contributor>
<dc:creator>Bischoff, Stephan</dc:creator>
<dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14340/2/1992_Rot_%20JEM_1292_176_1489_RANTES.pdf"/>
<dc:creator>Schall, Thomas</dc:creator>
<dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14340/2/1992_Rot_%20JEM_1292_176_1489_RANTES.pdf"/>
<dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
<dcterms:title>RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes</dcterms:title>
<bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14340"/>
<dcterms:bibliographicCitation>First publ. in: Journal of Experimental Medicine ; 176 (1992), 6. - pp. 1489-1495</dcterms:bibliographicCitation>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:language>eng</dc:language>
</rdf:Description>
</rdf:RDF> | |
| kops.description.openAccess | openaccessgreen | |
| kops.flag.knbibliography | false | |
| kops.identifier.nbn | urn:nbn:de:bsz:352-143407 | deu |
| kops.sourcefield | Journal of Experimental Medicine. 1992, <b>176</b>(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489 | deu |
| kops.sourcefield.plain | Journal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489 | deu |
| kops.sourcefield.plain | Journal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489 | eng |
| kops.submitter.email | regine.winter@uni-konstanz.de | deu |
| relation.isAuthorOfPublication | f61b843f-0378-4683-b89b-70ad6aec10ea | |
| relation.isAuthorOfPublication.latestForDiscovery | f61b843f-0378-4683-b89b-70ad6aec10ea | |
| source.bibliographicInfo.fromPage | 1489 | |
| source.bibliographicInfo.issue | 6 | |
| source.bibliographicInfo.toPage | 1495 | |
| source.bibliographicInfo.volume | 176 | |
| source.identifier.issn | 0022-1007 | |
| source.periodicalTitle | Journal of Experimental Medicine |
Dateien
Originalbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- 1992_Rot_ JEM_1292_176_1489_RANTES.pdf
- Größe:
- 776.42 KB
- Format:
- Adobe Portable Document Format
Lizenzbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- license.txt
- Größe:
- 1.92 KB
- Format:
- Plain Text
- Beschreibung:

